Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics
- PMID: 184086
Cyclid 3':5'-nucleotide phosphodiesterase. Interconvertible multiple forms and their effects on enzyme activity and kinetics
Abstract
An extract of rat liver or human platelet displayed three cyclic 3':5'-nucleotide phosphodiesterase activity peaks (I, II, and III) in a continuous sucrose density gradient when assayed with millimolar adenosine 3':5'-monophosphate (cAMP) or guanosine 3':5'-monophosphate (cGMP). The three fractions obtained from each nucleotide were not superimposable. The molecular weights corresponding to the three activity peaks of cAMP phosphodiesterase in rat liver were approximately: I, 22,000; II, 75,000; and III, 140,000. In both tissues, fraction I was barely detectable when assayed with micromolar concentrations of either nucleotide, presumably because fraction I has low affinity for cAMP and cGMP. Any one of the three forms upon recentrifugation on the gradient generated the others, indicating that they were interconvertible. The multiple forms appear to represent different aggregated states of the enzyme. The ratio of the three forms of cAMP phosphodiesterase in the platelet was shifted by dibutyryl cAMP (B2cAMP) and by the enzyme concentration. B2cAMP enhanced the formation of fraction I. Low enzyme concentration favored the equilibrium towards fraction I, while high enzyme concentration favored fraction III. When phosphodiesterase activities in the extract of rat liver, human platelets, or bovine brain were examined as a function of enzyme concentration, rectilinear rates were observed with micromolar, but not with millimolar cAMP or cGMP. The specific activity with millimolar cAMP was higher with low than with high protein concentrations, suggesting that the dissociated form catalyzed the hydrolysis of cAMP faster than that of the associated form. In contrast, the specific activity with millimolar cGMP was lower with low than with high protein concentrations. Supplementing the reaction mixture with bovine serum albumin to a final constant protein concentration did not affect the activity, suggesting that the concentration of the enzyme rather than that of extraneous proteins affected the enzyme activity. A change in enzyme concentration affected the kinetic properties of phosphodiesterase. A low enzyme concentration of cAMP phosphodiesterase yielded a linear Lineweaver-Burk plot, and a Km of 1.2 X 10(-4) M (bovine), 3 X 10(-5) M (platelet), or 5 X 10(-4) M (liver), while a high enzyme concentration yielded a nonlinear plot, and apparent Km values of 1.4 X 10(-4) M and 2 X 10(-5) M (brain), 4 X 10(-5) M and 3 X 10(-6) M (platelet), or 4 X 10(-5) M and 3 X 10(-6) (liver). Since a low enzyme concentration favored fraction I, the dissociated form, whereas a high enzyme concentration favored fraction III, the associated form, these kinetic constants suggest that the dissociated form exhibits a high Km and the associated form exhibits a low Km. In contrast, a high enzyme concentration gave a linear kinetic plot for cGMP phosphodiesterase, while a low enzyme concentration gave a nonlinear plot...
Similar articles
-
Human blood platelet 3': 5'-cyclic nucleotide phosphodiesterase. Isolation of low-Km and high-Km phosphodiesterase.Biochim Biophys Acta. 1976 Apr 8;429(2):485-97. doi: 10.1016/0005-2744(76)90296-5. Biochim Biophys Acta. 1976. PMID: 177073
-
Platelet cyclic 3':5'-nucleotide phosphodiesterase released by thrombin and calcium ionophore.J Biol Chem. 1976 Dec 10;251(23):7508-16. J Biol Chem. 1976. PMID: 187590
-
Multiple cyclic nucleotide phosphodiesterase activities from rat tissues and occurrence of a calcium-plus-magnesium-ion-dependent phosphodiesterase and its protein activator.Biochem J. 1975 Jan;146(1):109-20. doi: 10.1042/bj1460109. Biochem J. 1975. PMID: 167710 Free PMC article.
-
Cyclic nucleotide phosphodiesterases from rat anterior pituitary. Characterization of multiple forms and regulation by protein activator and Ca+.Eur J Biochem. 1977 Feb 15;73(1):73-82. doi: 10.1111/j.1432-1033.1977.tb11292.x. Eur J Biochem. 1977. PMID: 190011
-
Inhibitory and activators of cyclic nucleotide phosphodiesterase.Adv Cyclic Nucleotide Res. 1976;7:225-64. Adv Cyclic Nucleotide Res. 1976. PMID: 188316 Review. No abstract available.
Cited by
-
Histochemistry of nucleotidyl cyclases and cyclic nucleotide phosphodiesterases.Histochem J. 1988 May;20(5):249-68. doi: 10.1007/BF01745604. Histochem J. 1988. PMID: 2905351 Review. No abstract available.
-
Influence of theophylline on concentrations of cyclic 3',5'-adenosine monophosphate and cyclic 3',5'-guanosine monophosphate of rat brain.Neurochem Res. 1979 Oct;4(5):587-94. doi: 10.1007/BF00964436. Neurochem Res. 1979. PMID: 226900
-
Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.Neurochem Res. 1979 Dec;4(6):681-7. doi: 10.1007/BF00964465. Neurochem Res. 1979. PMID: 232543
-
Cyclic nucleotide phosphodiesterase activities in rat erythrocytes.Mol Cell Biochem. 1982 Apr 2;43(3):161-6. doi: 10.1007/BF00223007. Mol Cell Biochem. 1982. PMID: 6283333
-
Dunce mutants of Drosophila melanogaster: mutants defective in the cyclic AMP phosphodiesterase enzyme system.J Cell Biol. 1981 Jul;90(1):101-7. doi: 10.1083/jcb.90.1.101. J Cell Biol. 1981. PMID: 6265472 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources